Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

801
Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
801
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

721
Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
721
Cardiomyopathy I: Introduction and Classification01:25

Cardiomyopathy I: Introduction and Classification

869
Cardiomyopathy, or CMP, is a group of diseases affecting the myocardial structure, impairing its ability to pump blood effectively. This condition can lead to arrhythmias, heart failure, or sudden cardiac death.Cardiomyopathies are classified into primary and secondary categories:Primary Cardiomyopathy refers to conditions involving only the heart muscle that are often idiopathic (of unknown cause) or genetic. They primarily affect the myocardium without the involvement of other systemic...
869
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

805
Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
805
Cardiomyopathy IV: Restrictive Cardiomyopathy01:29

Cardiomyopathy IV: Restrictive Cardiomyopathy

920
Restrictive cardiomyopathy (RCM) is a rare heart muscle disease characterized by impaired ventricular filling due to stiffened ventricular walls, leading to significant diastolic dysfunction.EtiologyRestrictive cardiomyopathy can arise from both inherited and acquired diseases, many of which are systemic. It is categorized into four main types: infiltrative, storage, non-infiltrative, and endomyocardial diseases.Infiltrative diseases, such as amyloidosis, lead to RCM by depositing amyloid...
920
Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

1.5K
Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
1.5K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Guidelines for the Intraprocedural Imaging for Mitral Valve Transcatheter Edge-to-Edge Repair (M-TEER): Recommendations from the American Society of Echocardiography.

Journal of the American Society of Echocardiography : official publication of the American Society of Echocardiography·2026
Same author

Are obstructive müllerian anomalies an experimental model of Sampson's theory for endometriosis in vivo?

Fertility and sterility·2025
Same author

Innovative Mobile App (CPD By the Minute) for Continuing Professional Development in Medicine: Multimethods Study.

JMIR medical education·2025
Same author

A standardized set of metrics to assess the quality of anesthesia, perioperative care, and acute pain management in Canada: a multidisciplinary modified Delphi study.

Canadian journal of anaesthesia = Journal canadien d'anesthesie·2025
Same author

Metrics to assess the quality of anesthesia, perioperative care, and acute pain management in Canada: a scoping review.

Canadian journal of anaesthesia = Journal canadien d'anesthesie·2025
Same author

Clinical spreading of muscle weakness in amyotrophic lateral sclerosis (ALS): a study in 910 patients.

Journal of neurology·2024

Related Experiment Video

Updated: Apr 17, 2026

Investigating the Pathogenesis of MYH7 Mutation Gly823Glu in Familial Hypertrophic Cardiomyopathy using a Mouse Model
03:45

Investigating the Pathogenesis of MYH7 Mutation Gly823Glu in Familial Hypertrophic Cardiomyopathy using a Mouse Model

Published on: August 8, 2022

4.4K

Hypertrophic cardiomyopathy: a review.

Nadia Hensley1, Jennifer Dietrich, Daniel Nyhan

  • 1From the Department of Anesthesiology and Critical Care Medicine, Johns Hopkins Hospital, Baltimore, Maryland.

Anesthesia and Analgesia
|February 20, 2015
PubMed
Summary

Hypertrophic cardiomyopathy (HCM) is a common condition anesthesiologists encounter. This review details HCM diagnosis, genetics, and perioperative management for noncardiac surgery and labor.

More Related Videos

An Approach to Study Shape-Dependent Transcriptomics at a Single Cell Level
06:02

An Approach to Study Shape-Dependent Transcriptomics at a Single Cell Level

Published on: November 2, 2020

6.3K
Scanning Electron Microscopy of Macerated Tissue to Visualize the Extracellular Matrix
10:21

Scanning Electron Microscopy of Macerated Tissue to Visualize the Extracellular Matrix

Published on: June 14, 2016

10.8K

Related Experiment Videos

Last Updated: Apr 17, 2026

Investigating the Pathogenesis of MYH7 Mutation Gly823Glu in Familial Hypertrophic Cardiomyopathy using a Mouse Model
03:45

Investigating the Pathogenesis of MYH7 Mutation Gly823Glu in Familial Hypertrophic Cardiomyopathy using a Mouse Model

Published on: August 8, 2022

4.4K
An Approach to Study Shape-Dependent Transcriptomics at a Single Cell Level
06:02

An Approach to Study Shape-Dependent Transcriptomics at a Single Cell Level

Published on: November 2, 2020

6.3K
Scanning Electron Microscopy of Macerated Tissue to Visualize the Extracellular Matrix
10:21

Scanning Electron Microscopy of Macerated Tissue to Visualize the Extracellular Matrix

Published on: June 14, 2016

10.8K

Area of Science:

  • Cardiology
  • Anesthesiology

Background:

  • Hypertrophic cardiomyopathy (HCM) is a relatively common cardiac disorder.
  • Historically considered obscure, HCM is now diagnosed more frequently due to improved understanding and diagnostic capabilities.
  • Patients with HCM exhibit genotypic and phenotypic variability, with some having the genotype but not the phenotype of left ventricular hypertrophy.

Purpose of the Study:

  • To provide a comprehensive review of hypertrophic cardiomyopathy (HCM) for noncardiac anesthesiologists.
  • To discuss the clinical presentation, genetic mutations, and diagnostic modalities for HCM.
  • To outline the perioperative management strategies for patients with HCM undergoing noncardiac surgery and for parturients with HCM.

Main Methods:

  • Review of current literature on hypertrophic cardiomyopathy (HCM).
  • Emphasis on diagnostic roles of echocardiography and cardiac magnetic resonance imaging.
  • Discussion of pharmacotherapy, implantable cardiac defibrillators, and surgical interventions (myectomy, septal ablation).

Main Results:

  • Accurate diagnosis of HCM is crucial for effective perioperative management.
  • Echocardiography is vital for assessing left ventricular hypertrophy, outflow tract gradients, cardiac function, and mitral valve status.
  • Cardiac MRI aids in determining the extent of hypertrophy and mitral valve/papillary muscle abnormalities.

Conclusions:

  • HCM diagnosis and management have advanced significantly.
  • A multi-modal approach including pharmacotherapy and interventions is used to manage HCM.
  • Anesthesiologists require knowledge of HCM for safe perioperative care of affected patients.